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Abstract
Background Calprotectin (S100A8/S100A9), a heterodimeric EF-hand  Ca2+ binding protein, are abundant in cytosol of 
neutrophils and are involved in inflammatory processes and several cancerous pathogens.
Objective The purpose of the present systematic review is to evaluate the pro- and anti-tumorigenic functions of calprotectin 
and its relation to inflammation.
Materials and methods We conducted a review of studies published in the Medline (1966–2018), Scopus (2004–2018), 
ClinicalTrials.gov (2008–2018) and Google Scholar (2004–2018) databases, combined with studies found in the reference 
lists of the included studies.
Results Elevated levels of S100A8/S100A9 were detected in inflammation, neoplastic tumor cells and various human can-
cers. Recent data have explained that many cancers arise from sites of infection, chronic irritation, and inflammation. The 
inflammatory microenvironment which largely includes calprotectin, has an essential role on high producing of inflammatory 
factors and then on neoplastic process and metastasis.
Conclusion Scientists have shown different outcomes in inflammation, malignancy and apoptosis whether the source of 
the aforementioned protein is extracellular or intracellular. These findings are offering new insights that anti-inflammatory 
therapeutic agents and anti-tumorigenic functions of calprotectin can lead to control cancer development.
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Introduction
The S100s are low molecular weight proteins which repre-
sent the largest subgroup within the  Ca2+-binding EF-hand. 
This superfamily comprising of more than 20 members in 
the human genome, it’s genes cluster are located on chromo-
some 1q21 and similar numbers have been found in other 
mammalian based on genomic analysis [1]. They were first 
isolated originally from bovine brain tissue by Moore et al. 
in 1965 and represent small acidic proteins with a unique 
solubility in a solution of 100% saturated ammonium sulfate, 
which termed “S100” [2, 3]. Calprotectin, a members of 
S100s proteins, is a heterodimeric calcium-binding protein 
consisting of S100A8 and S100A9 subunits [4]. They are 
expressed in a wide variety of cell types and are abundant 
in myeloid cells such as: neutrophils, monocytes, keratino-
cytes and early differentiation states of macrophages. So, 
S100A8 and S100A9 are called myeloid-related protein and 
are known as: MRP-8 and MRP-14 too [5, 6]. Furthermore, 
S100A8 and S100A9 are denoted as Calgranulin A and Cal-
granulin B respectively which reflect their calcium-binding 
properties and highly overexpressed in granulocytes. The 
S100A8/S100A9 are released by activated granulocytes 
and act in a cytokine-like manner by binding to cell surface 
receptors which trigger signaling pathways involved in the 
inflammatory processes and play critical roles in numer-
ous cellular processes includes cell cycle progression, cell 
survival, proliferation, differentiation, and cell migration. 
Furthermore, they exert a wide range of functions including: 
calcium homeostasis regulation which involved in proteins 
phosphorylation, cytoskeletal components rearrangement, 
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